MAPT and Alzheimer disease: The immunolabeling and solvent-based clearing method iDISCO has also been used to evaluate tau pathology and Aβ plaques using antibodies and Congo red labeling in APPswe/PSEN1ΔE9 and 3xTg-AD transgenic mice and human AD brains (Liebmann et al., 2016).